To reach these ambitious targets, ‘Intensified research and innovation’ is needed to develop more effective interventions to detect, cure and prevent TB. This constitutes the third pillar of the End TB Strategy. To strengthen TB research in low- and middle-income countries most affected by TB, WHO supports developing and implementing a national TB research plan. Evidence gaps and research needs identified during tuberculosis policy guideline development pdf, 944kb; Toolkit for developing a national TB research plan pdf, 2.4Mb; International roadmap for TB research pdf, 1.22Mb; Global Investments in Tuberculosis Research … Major hurdles in TB control and elimination 8 3. Proceedings of the 2016 Texas Tuberculosis Research Symposium 2016: Research and Clinical Collaboration within Texas towards Elimination of TB Edited … Preface: Tuberculosis research in The Netherlands: Innovation to accelerate global tuberculosis elimination 2 By Mario C. Raviglione, Director Global TB Programme, WHO, Geneva 2 Executive summary 4 1. To promote and enhance TB research globally, WHO encourages building strong research partnerships and networks and securing robust funding for research. WHO, with contributions from many stakeholders, has developed a. These are needed along all research spectrum (from basic science to operational research) and requires a strong and self-sustained TB research community. Over 4 000 people die of TB every day and up to 2 billion are infected with the causative agent, Mycobacterium tuberculosis.

21 March 2019 - The World Health Organization’s (WHO) End TB Strategy aims to end the global TB epidemic by 2030. The TBESC is designed to build the scientific research capacities of state and metropolitan TB control programs, participating laboratories, academic institutions, hospitals, and both non- and for-profit organizations.

3rapid diagnostic tests were made available in the past decade, and diagnostic tools are under development. RESEARCH TO FIGHT TUBERCULOSIS The challenge Tuberculosis (TB) is the leading infectious disease killer, taking the lives of 1.7 million people each year. 12vaccine candidates are in clinical trial, 2new drugs were introduced in the past decade, and another eight new or repurposed drugs are under development. To promote and enhance TB research globally, WHO encourages building strong research partnerships and networks and securing robust funding for research. It targets a 90% reduction in TB mortality, a 80% decline in TB incidence and zero catastrophic costs for TB-affected households. WHO is developing a Global Strategy for TB Research and Innovation (Global Strategy) in consultation with Member States, Civil Society, partners and other key stakeholders, for consideration by the Executive Board at its 146th session in January 2020. WHO, with contributions from many stakeholders, has developed a Global Action Framework for TB Research to foster high-quality TB research over the next 10 years (2015 to 2025), both at country and global levels.

14-16 March 2018, Glion-sur-Montreux, Switzerland, Coronavirus disease outbreak (COVID-2019), Coronavirus disease outbreak (COVID-19) », Supranational Reference Laboratory Network, Addressing needs of vulnerable populations, Global Task Force on TB impact measurement, Global Task Force on Digital Health for TB, TPPs and priority digital health products for TB, Download the Global Action Framework for TB research, Download the Toolkit for developing a national TB research plan, Key steps in developing and implementing a national TB research plan, GSK’s Investigational Vaccine Candidate M72/AS01E shows promise for prevention of TB disease in a Phase 2b trial conducted in Kenya, South Africa and Zambia, Report of the Technical Consultation on Advances in Clinical Trial Design for Development of New TB Treatments, FAQs on the investigational vaccine candidate M72/AS01E, Evidence gaps and research needs identified during tuberculosis policy guideline development, Toolkit for developing a national TB research plan, Global Investments in Tuberculosis Research and Development: Past, Present, and Future, Priorities in Operational Research to Improve Tuberculosis Care and Control, Technical support and coordination to end TB.

Rationale and justification 6 2. PDF | Tuberculosis (TB) remains one of the deadliest infectious diseases responsible for millions of deaths annually across the world.